Insider Transactions in Q1 2021 at C4 Therapeutics, Inc. (CCCC)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2021
|
Marc A Cohen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
536
+8.78%
|
$1,072
$2.11 P/Share
|
|
Feb 03
2021
|
Stewart Fisher Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,300
+3.73%
|
$16,600
$2.91 P/Share
|
|
Jan 22
2021
|
Kenneth Carl Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,548
+0.63%
|
$4,644
$3.07 P/Share
|